CBCari A. Beesley

Cari A. Beesley

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Cari A. Beesley has a total of 124 co-authors. Here are the top co-authors by number of shared publications:

  • Jay E. Gee

    Bacterial Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention

    8 shared publications
  • Alex R. Hoffmaster

    CDC, Natl Ctr Emerging & Zoonot Infect Dis, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA

    6 shared publications
  • Chung K. Marston

    Bacterial Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329-4018, USA

    4 shared publications
  • David D. Blaney

    National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA

    4 shared publications
  • Christopher A. Gulvik

    Bacterial Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329-4018, USA

    3 shared publications
  • Chung K. Marston

    CDC, Natl Ctr Emerging & Zoonot Infect Dis, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA

    3 shared publications

Latest Publications

  • Open Access

    Molecular Epidemiology and Phylogeography of Domestically Established Bacillus anthracis Isolates Collected in the United States from 1982 to 2013

    by Chung K. Marston, Christopher A. Gulvik, Cari A. Beesley, Mili Sheth, Mark Burroughs, Amy K. Swinford, Matthew M. Erdman, Kristin A. Clothier, Rajesh Maganbhai Parmar, Maureen M. Sullivan, et al.

    Bacillus anthracis is endemic in the United States causing periodic outbreaks in wildlife and domestic animals. Currently, human anthrax cases in the U.S. are rare but were common in the 1950s–1960s due to industrial work with imported B. anthracis-contaminated animal products. Multiple-locus variable-number tandem repeat analysis (MLVA) initially differentiated B. anthracis into 89 genotypes and two major clades. Recently, whole-genome sequencing (WGS) was implemented to differentiate B. anthracis which allows for higher resolution and can eliminate risk of homoplasy. To assess the molecular diversity of U.S.-established isolates, we performed MLVA and WGS on 81 B. anthracis isolates from domestic animals or soil. By MLVA, most isolates (n = 58, 72%) were in the Western North America (WNA)/A1.a cluster. Isolates were also observed in the Ames (A3.b), Vollum (A4), and Group B clusters. Using WGS, two major clades (A and B) and four clusters (WNA, Ames, Vollum, Group B) were identified. The four WGS clusters correlated with previously established MLVA clusters (A1a, A3b, A4, and B1, respectively). Further differentiation of the WNA cluster showed that isolates collected from the same state generally clustered together and more broadly by region (west, central, Texas). In the current study, we provide an update on the genetic diversity of domestically established B. anthracis strains using MLVA and WGS. WGS was able to provide additional differentiation, particularly within the WNA cluster, which can lend assistance in epidemiological investigations.

  • Open Access

    Investigating Anthrax-Associated Virulence Genes among Archival and Contemporary Bacillus cereus Group Genomes

    by Susanna J. Sabin, Cari A. Beesley, Chung K. Marston, Taylor K. Paisie, Christopher A. Gulvik, Gregory A. Sprenger, Jay E. Gee, Rita M. Traxler, Melissa E. Bell, John R. McQuiston, et al.

    Bacillus anthracis causes anthrax through virulence factors encoded on two plasmids. However, non-B. anthracis organisms within the closely related, environmentally ubiquitous Bacillus cereus group (BCG) may cause an anthrax-like disease in humans through the partial adoption of anthrax-associated virulence genes, challenging the definition of anthrax disease. To elucidate these phenomena and their evolutionary past, we performed whole-genome sequencing on non-anthracis BCG isolates, including 93 archival (1967–2003) and 5 contemporary isolates (2019–2023). We produced annotated genomic assemblies and performed a pan-genome analysis to identify evidence of virulence gene homology and virulence gene acquisition by linear inheritance or horizontal gene transfer. At least one anthrax-associated virulence gene was annotated in ten isolates. Most homologous sequences in archival isolates showed evidence of pseudogenization and subsequent gene loss. The presence or absence of accessory genes, including anthrax-associated virulence genes, aligned with the phylogenetic structure of the BCG core genome. These findings support the hypothesis that anthrax-associated virulence genes were inherited from a common ancestor in the BCG and were retained or lost across different lineages, and contribute to a growing body of work informing public health strategies related to anthrax surveillance and identification.


  • Open Access

    Notes from the Field: Anthrax on a Sheep Farm in Winter — Texas, December 2023–January 2024

    by Julie M. Thompson, Kelly Spencer, Melissa Maass, Susan Rollo, Cari A. Beesley, Chung K. Marston, Alex R. Hoffmaster, William A. Bower, Maribel Gallegos Candela, John R. Barr, et al.

    This report describes an unexpected anthrax outbreak during winter at a Texas sheep farm.

  • Open Access

    Strains Associated with Two 2020 Welder Anthrax Cases in the United States Belong to Separate Lineages within Bacillus cereus sensu lato

    by Laura M. Carroll, Chung K. Marston, Cari B. Kolton, Christopher A. Gulvik, Jay E. Gee, Zachary P. Weiner, Jasna Kovac

    Anthrax-causing members of Bacillus cereus sensu lato (s.l.) pose a serious threat to public health. While most anthrax-causing strains resemble B. anthracis phenotypically, rare cases of anthrax-like illness caused by strains resembling “B. cereus” have been reported. Here, whole-genome sequencing was used to characterize three B. cereus s.l. isolates associated with two 2020 welder anthrax cases in the United States, which resembled “B. cereus” phenotypically. Comparison of the three genomes sequenced here to all publicly available, high-quality B. cereus s.l. genomes (n = 2890 total genomes) demonstrated that genomes associated with each case effectively belonged to separate species at the conventional 95% average nucleotide identity prokaryotic species threshold. Two PubMLST sequence type 78 (ST78) genomes affiliated with a case in Louisiana were most closely related to B. tropicus and possessed genes encoding the Bps exopolysaccharide capsule, as well as hemolysin BL (Hbl) and cytotoxin K (CytK). Comparatively, a ST108 genome associated with a case in Texas was most closely related to B. anthracis; however, like other anthrax-causing strains most closely related to B. anthracis, this genome did not possess Bps-, Hbl-, or CytK-encoding genes. Overall, results presented here provide insights into the evolution of anthrax-causing B. cereus s.l.


  • Open Access

    Case Report: A Fatal Case of Latent Melioidosis Activated by COVID-19

    by Uday Gulati, Ananya C. Nanduri, Prateek Juneja, David Kaufman, Mindy G. Elrod, Cari B. Kolton, Jay E. Gee, Kristen Garafalo, David D. Blaney

    : Melioidosis, endemic in Southeast Asia and Northern Australia, is an uncommon but frequently fatal opportunistic infection caused by the Gram-negative saprophyte Burkholderia pseudomallei. We describe the first reported case of activation of latent melioidosis concurrent with COVID-19-associated lymphopenia and neutropenia in the setting of poorly controlled diabetes. A 43-year-old HIV-positive, diabetic man presented to the emergency department with persistent chills and progressive dyspnea. He was admitted for hypoxia. Chest X-ray showed bilateral parenchymal infiltrates suspicious for COVID-19. Shortly after admission, he became acutely encephalopathic, had a generalized seizure, and was transferred to the intensive care unit after intubation. Further workup showed severe neutropenia and lymphopenia. The patient received empiric antimicrobial coverage and was found to be severe acute respiratory syndrome coronavirus 2 positive. He deteriorated rapidly with refractory shock and persistent hypoxemia, and died 40 hours after admission. Blood cultures and sputum cultures obtained via bronchoalveolar lavage returned positive for Burkholderia pseudomallei. Given confirmed compliance with antiretrovirals, stable CD4 counts, and no recent foreign travel, the patient likely contracted the B. pseudomallei infection from travel to Southeast Asia many years prior and only became symptomatic after succumbing to severe acute respiratory syndrome coronavirus 2 infection. This case highlights the importance of considering activation of latent opportunistic infections by COVID-19 in immunocompromised patients.


  • Differentiating New from Newly Detected: Melioidosis in Yap, Federated States of Micronesia

    by Leisha D. Nolen, Eric Lirow, Jay E. Gee, Mindy G. Elrod, Cari B. Kolton, Lindy Liu, William A. Bower, Marissa K. Person, Maria Marfel, David D. Blaney

    Melioidosis is a bacterial infection caused by exposure to water or soil that contains Burkholderia pseudomallei (Bp). Burkholderia pseudomallei is endemic to many tropical and subtropical areas of the world. In 2013, the first case of melioidosis was recognized in Yap, the Federated States of Micronesia. Six additional cases were identified in the subsequent 3 years. An investigation was initiated to understand the epidemiology of melioidosis in Yap. Serum from family and community members of the identified cases were tested for antibodies to Bp. Archived serum from a 2007 Zika serosurvey were also tested for antibodies to Bp. Sequencing of bacterial isolates was performed to understand bacterial phylogeny. Soil and water were tested for the presence of Bp in the environment by culture and PCR. None of the affected patients had a history of travel to melioidosis-endemic countries. Two of the 34 (5.8%) samples from the field investigation and 67 (11.7%) of the historical samples demonstrated serologic evidence of prior Bp exposure. No Bp were detected from 30 soil or water samples. Genotype analysis showed highly related Bp isolates that were unique to Yap. Melioidosis is likely to be endemic to Yap; however, it has only recently been recognized by the clinical community in country. Further investigation is needed to understand the local sites that harbor Bp and represent the highest risk to the community.


  • Detection of Bacillus anthracis in animal tissues using InBios active anthrax detect rapid test lateral flow immunoassay

    by Cari B. Kolton, Chung K. Marston, Robyn A. Stoddard, Caitlin Cossaboom, Johanna S. Salzer, Thomas R. Kozel, Marcellene A. Gates‐Hollingsworth, Christopher A. Cleveland, Alec T. Thompson, Martha F. Dalton, et al.

    The Active Anthrax Detect (AAD) Rapid Test lateral flow immunoassay is a point‐of‐care assay that was under investigational use for detecting Bacillus anthracis capsular polypeptide (polyglutamic acid) in human blood, serum, and plasma. Small sample volumes, rapid results, and no refrigeration required allow for easy use in either the field or laboratory. Although the test was developed for use in suspect cases of human inhalation anthrax, its features also make it a potentially powerful tool for testing suspect animal cases. We tested animal tissue samples that were confirmed or ruled out for B. anthracis. The AAD Rapid Tests were also deployed in the field, testing animal carcasses during an anthrax outbreak in hippopotami (Hippopotamus amphibius) and Cape buffalo (Syncerus caffer) in Namibia. Evaluation of all samples showed a specificity of 82% and sensitivity of 98%. However, when the assay was used on specimens from only fresh carcasses (dead for less than 24 hours), the specificity increased to 96%. The AAD Rapid Test is a rapid and simple screening assay, but confirmatory testing needs to be done, especially when the age of the sample (days animal has been deceased) is unknown.


  • Open Access

    Bacillus anthracis gamma phage lysis among soil bacteria: an update on test specificity

    by Cari B. Kolton, Nicole L. Podnecky, Sean V. Shadomy, Jay E. Gee, Alex R. Hoffmaster

    Bacillus anthracis, which causes anthrax in humans and animals, is enzootic in parts of the U.S. state of Texas where cases are typically reported in animals annually. The gamma phage lysis assay is a common diagnostic method for identification of B. anthracis and is based on the bacterium’s susceptibility to lysis. This test has been shown to be 97% specific for B. anthracis, as a small number of strains of other Bacillus spp. are known to be susceptible. In this study, we evaluated the performance of a combination of B. anthracis diagnostic assays on 700 aerobic, spore-forming isolates recovered from soil collected in Texas. These assays include phenotypic descriptions, gamma phage susceptibility, and real-time polymerase chain reaction specific for B. anthracis. Gamma phage-susceptible isolates were also tested using cell wall and capsule direct fluorescent-antibody assays specific for B. anthracis. Gamma phage-susceptible isolates that were ruled out as B. anthracis were identified by 16S rRNA gene sequencing. We identified 29 gamma phage-susceptible isolates. One was confirmed as B. anthracis, while the other 28 isolates were ruled out for B. anthracis by the other diagnostic tests. Using 16S rRNA gene sequencing results, we identified these isolates as members of the B. cereus group, Bacillus sp. (not within B. cereus group), Lysinibacillus spp., and Solibacillus silvestris. Based on these results, we report a specificity of 96% for gamma phage lysis as a diagnostic test for B. anthracis, and identified susceptible isolates outside the Bacillus genus. In this study we found gamma phage susceptibility to be consistent with previously reported results. However, we identified non-B. anthracis environmental isolates (including isolates from genera other than Bacillus) that are susceptible to gamma phage lysis. To date, susceptibility to gamma phage lysis has not been reported in genera other than Bacillus. Though these isolates are not of clinical origin, description of unexpected positives is important, especially as new diagnostic assays for B. anthracis are being developed based on gamma phage lysis or gamma phage proteins.


  • Open Access

    PersistentBacillus cereusBacteremia in 3 Persons Who Inject Drugs, San Diego, California, USA

    by Gabrielle Schaefer, Wesley Campbell, Jeffrey Jenks, Cari Beesley, Theodoros Katsivas, Alex Hoffmaster, Sanjay R. Mehta, Sharon Reed

    Bacillus cereus is typically considered a blood culture contaminant; however, its presence in blood cultures can indicate true bacteremia. We report 4 episodes of B. cereus bacteremia in 3 persons who inject drugs. Multilocus sequence typing showed that the temporally associated infections were caused by unrelated clones.


  • Contact Investigation of Melioidosis Cases Reveals Regional Endemicity in Puerto Rico

    by Thomas J. Doker, Tyler M. Sharp, Brenda Rivera-Garcia, Janice Perez-Padilla, Tina J. Benoit, Esther M. Ellis, Mindy G. Elrod, Jay E. Gee, Wun-Ju Shieh, Cari A. Beesley, et al.

    Background. Melioidosis results from infection with Burkholderia pseudomallei and is associated with case-fatality rates up to 40%. Early diagnosis and treatment with appropriate antimicrobials can improve survival rates. Fatal and nonfatal melioidosis cases were identified in Puerto Rico in 2010 and 2012, respectively, which prompted contact investigations to identify risk factors for infection and evaluate endemicity.